Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines
Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus ...
BBI Solutions appoints Alexander A. Socarrás as Chief Executive Officer
BBI Solutions Limited ("BBI"), global leader in the development and manufacture of IVD reagents, announces a CEO succession. After 7 years as ...
News Medical1d
Collaborative effort targets better nutrition for pregnant women and children
Poor nutrition during pregnancy can have serious consequences for both maternal and child health. A new research collaboration – 'Mother's Micronutrient Supplement for Pregnancy and Lactation' (MoMS) ...
Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...
Eccogene Announces Formation of Scientific Advisory Board
Juleen R. Zierath, Ph.D. - Professor of Clinical Integrative Physiology at Karolinska Institutet, Stockholm, Sweden, and Professor of Integrative Physiology and Executive Director at the Novo Nordisk ...
The Bill and Melinda Gates Foundation is one of the world's largest charitable organizations. Here's what to know.
The Bill and Melinda Gates Foundation is a charitable organization that has spent tens of billions of dollars fighting global ...
Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...